Annual Drug Patent Expirations for PERFOROMIST
Perforomist is a drug marketed by Mylan Speclt and is included in one NDA. It is available from one supplier. There are six patents protecting this drug and one Paragraph IV challenge.
PERFOROMIST drug price trends.
Drug patent litigation for PERFOROMIST.
This drug has fourteen patent family members in nine countries.
The generic ingredient in PERFOROMIST is formoterol fumarate. One supplier is listed for this compound. Additional details are available on the formoterol fumarate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com